Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in Thermo Fisher Scientific Inc./Life Technologies Corporation merger agreement
| April 14, 2013 • Antitrust Risk-shifting • $13.6 billion (plus assumed debt). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.